Hualan Bio
Hualan Bio, officially known as Hualan Biological Engineering Inc., is a leading biotechnology company headquartered in China (CN). Established in 1992, Hualan Bio has made significant strides in the biopharmaceutical industry, focusing on the research, development, and production of vaccines and diagnostic reagents. With major operational regions across Asia and expanding globally, the company has positioned itself as a key player in public health. Hualan Bio's core products include a range of human and animal vaccines, as well as innovative diagnostic solutions that stand out for their quality and efficacy. The company has achieved notable milestones, including several national and international certifications, reinforcing its commitment to safety and excellence. As a pioneer in the biotechnology sector, Hualan Bio continues to contribute to advancements in healthcare, solidifying its reputation as a trusted name in the industry.
DitchCarbon Score
How does Hualan Bio's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hualan Bio's score of 5 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hualan Bio's reported carbon emissions
In 2023, Hualan Bio reported total carbon emissions of approximately 6,812,060 kg CO2e, a slight increase from about 6,798,620 kg CO2e in 2022. The emissions breakdown for 2023 includes about 252,070 kg CO2e from Scope 1 and approximately 6,559,990 kg CO2e from Scope 2. Despite the increase in total emissions, Hualan Bio has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The company has not committed to any climate pledges or set science-based targets for emissions reduction. As a significant player in the biotechnology sector, Hualan Bio's emissions profile reflects the industry's challenges in managing greenhouse gas emissions, particularly in Scope 2, which encompasses indirect emissions from purchased electricity. The company’s emissions intensity, measured in relation to revenue, was approximately 0.002987 kg CO2e per unit of revenue in 2023, indicating a need for enhanced sustainability strategies moving forward.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 63,625.2 | 000,000 |
| Scope 2 | 6,734,995 | 0,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hualan Bio is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
